Skip to content
Screener

Zevra Therapeutics, Inc. ZVRA Business Segments — Investment Income, Interest

Similar metrics at other companies

Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — Investment Income, Interest
$3M-25.0%
SiTime Corporation logo
SITMReportable Segment — Investment Income, Interest
$12.55M+194%
BOB
BOBSReportable segment — Investment Income, Interest
$1.62M+514%
Claritev Corporation logo
CTEVReportable Segment — Investment Income, Interest
$195K-39.6%
Stitch Fix logo
SFIXReportable Segment — Investment Income, Interest
$2.12M-19.2%
Cadence Design Systems logo
CDNSReportable Segment — Investment Income, Interest
$9.94M-61.7%

Other financials

Income statement

See full
Revenue$39.7M+53.3%
Gross profit$38.1M+182%
Operating income$16.8M+124%
Net income$8.8M-88.3%
EPS (diluted)$0.14-88.4%

Balance sheet

See full
Cash & equivalents$145.3M+205%
Total debt$1.5M-97.6%
Total equity$217.7M+85.7%
Total assets$302.7M+18.1%

Cash flow

See full
Operating cash flow$17.0M+573%
CapEx$217.0K+1.9%
Free cash flow$16.8M+541%

Valuation

See full
Market cap$686.48M+6.6%
Enterprise value$542.65M-17.8%
P/E11.8×-232×
P/S-5.3×

Profitability

See full
Gross margin95.5%+23.5pp
Operating margin-103.9%-43.0pp
Net margin42.8%+38.6pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity34.8%+31.3pp
Debt / equity-0.5×
Current ratio5.2×-2.7×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001434647-26-000068
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Other segment items:
Impairment of intangible assets58,71058,710
Income tax expense4,0422,19910,9573,381
Interest income(1,477)(2,257)(3,661)(2,975)
Depreciation and amortization expense3161,6517323,300
Interest expense2,0091,7113,978
Other income, net (a)6,985(135,353)(26,718)(138,738)
Segment net income$8,752$74,707$46,642$71,608

ITEM 1.FINANCIAL STATEMENTS

FAQ

What is Zevra Therapeutics, Inc.'s business segments — investment income, interest?
Zevra Therapeutics, Inc. (ZVRA) reported business segments — investment income, interest of $1.48M in Q2 2026.
How has Zevra Therapeutics, Inc.'s business segments — investment income, interest changed year-over-year?
Zevra Therapeutics, Inc.'s business segments — investment income, interest decreased by 34.6% year-over-year, from $2.26M to $1.48M.
What does business segments — investment income, interest mean?
Represents interest income earned on cash balances, short-term investments, or other financial assets held by the segment. This metric highlights the segment's ability to generate non-operating returns from its liquid capital resources.

Ask your AI about Zevra Therapeutics, Inc.'s business segments — investment income, interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude